Centro de Investigación Biomédica en Red, Bioingeniería, Biomateriales y Nanomedicina

The Biomedical Networking Research Center of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) is one of the 11 thematic areas of CIBER. CIBER groups some of the main Spanish research groups (more than 400) in biomedicine, located in more than 100 institutions distributed around Spain.

Av. Monforte de Lemos, 3-5. Pabellón 11. Planta 0 28029 Madrid

Method for rapid detection of Candida auris and diagnosis of infection caused by this pathogen

managed by CIBER-BBN

TECHNOLOGY DESCRIPTION

The present invention describes a biosensor for the detection of DNA of C. auris and/or diagnosis of infection caused by this new and multi-resistant species of pathogenic fungus that solves the problems of the devices and methods of the state of the art.
This innovative technology allows a fast and easy detection of C. auris with a high level of sensitivity and selectivity. Based on this biosensor, a detection method and a method of diagnosing diseases caused by said pathogenic fungus have also been developed.
The biosensor is based on a porous material that comprises an indicator and single-stranded DNA oligonucleotides that specifically recognize a region of Candida auris DNA. When the Candida auris is present in the medium, the oligonucleotides recognize that DNA region of the fungus, bind to it, and the release of an indicator by which the fungus can be detected occurs.
This method allows a fast and easy detection of C. auris with a high level of sensitivity and selectivity.
No specialized personnel are required, this is a simple method of detection by direct visual observation of the medium.
Detection and / or quantification of diagnosis are carried out in one hour, reducing the time of tests used routinely.
The in vitro diagnostic method developed is suitable for detecting and/or quantifying C. auris in samples from subjects infected with the fungus. Subjects are human, but can also be animals, preferably mammals.
Clinical samples suitable for the use of the invention are: body fluids, such as blood, serum, sputum, pleural fluid, peritoneal fluid, synovial fluid, and cerebrospinal fluid.
A Kit has been prepared comprising biosensor, buffers, delivery vehicles, material supports, positive and/or negative control components, and use instructions.

BENEFITS

This innovative technology allows a fast and easy detection of Candida auris with a high level of sensitivity and selectivity. Based on this biosensor, a detection method and a method of diagnosing diseases caused by said pathogenic fungus have also been developed.

LIMITATIONS

To be determined during further development.

APPLICATIONS

Patient need adressed:
Infection of candida auris
(Candidemia, Candidiasis)

MATERIALS

Readiness Level (TRL)

3
experimental proof of concept(The pie chart refers to the entire portfolio contained in the database of the helpdesk)

Technology Readiness Levels (TRL) are a method of estimating technology maturity of Critical Technology Elements (CTE) of a program during the acquisition process. The use of TRLs enables consistent, uniform, discussions of technical maturity across different types of technology.

Patent Grading Report

Patent Grading Report

The Grading Patents Report evaluates and grades US patents

Sample Buy from Wisdomain

STATUS

Current status

Spanish patent application (Priority date: April 27, 2020). Suitable for international extension (PCT application)

AVAILABILITY

Available for

Licensing or Assignment

INVENTOR / TEAM

Sara Santiago, Luis Pla, Ma. Angeles Tormo, Elena Aznar, Alba Cecilia Ruiz, Eulogio Valentin, Javier Peman, Ramon Martinez

GENERAL ENQUIRIES
LICENSING REQUEST

Case manager: Aida Castellanos Paez

EU-Japan Centre
European CommissionMeti